Properties
Description
Tivantinib inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis.
Molecular Formula
C23H19N3O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tivantinib targets c-MET, aiding in research of targeted therapies to address MET-associated oncogenic pathways.
